The State Food and Drug Administration will work out the standard of plant extracts for health food

The problem of Ginkgo biloba extract continued to ferment The State Food and Drug Administration recently released a list of health care enterprises involving unqualified raw materials, including some well-known enterprises In response to this phenomenon, the State Food and Drug Administration will start to formulate relevant regulations to fill the blank of the standard of plant raw material extract of health food in China In response, Jin Zonglian, a national health food review expert, said that the incident reflected the risks of outsourcing raw materials and the lack of regulatory standards for health food extract industry "There are 14000 kinds of health food approved in China, and only 2000 to 3000 kinds of products are in circulation in the market Some of them can't enter the market, some of them can't enter the market and have to exit the market The main reason is that the quality is not up to the standard." According to Jin Zonglian, the problem of Ginkgo biloba extract exposed the risk of outsourcing raw materials Therefore, to improve the quality of raw materials is the key factor to ensure the vitality of enterprises and products Jin also said that in addition to the current exposure of illegal extraction production process, the content of heavy metals in Ginkgo biloba extract is also prominent "In fact, many of the extracts involved in health food lack national standards." Jinzonglian said that, taking the current popular antioxidant health food as an example, there have been many products with grape seed extract as raw material on the market, and the production process, raw material extraction and matching principle of raw material extract are lack of standards and specifications, so the quality is difficult to control According to Jin Zonglian, the new "food safety law" proposed for the first time the "list of health food raw materials", which will play a normative role in the extract Market after its establishment, and consumers will have an authoritative basis for purchasing It is reported that Ginkgo biloba extract is widely used in medicine, health products, food additives, functional drinks and cosmetics In May this year, the regulatory authorities found in the flight inspection that some enterprises changed the extraction process without authorization, using 3% hydrochloric acid instead of dilute ethanol to prepare Ginkgo biloba extract, while according to the national production standards, dilute ethanol should be used for extraction According to the State Food and drug administration, there is a risk of "decomposing the effective ingredients of drugs and affecting the efficacy of drugs" by changing the extraction process without authorization Statistics show that 157 enterprises in China currently use Ginkgo biloba extract to produce health food Previously, the State Food and Drug Administration announced that 21 health food enterprises, including Dalian Zhenao group, Tangshen Beijian, limitless Co., Ltd and Ruxin (China) Co., Ltd., purchased problematic Ginkgo biloba extract from Guilin Xingda Pharmaceutical Co., Ltd and Ningbo Lihua Pharmaceutical Co., Ltd According to Huang Jiansheng, deputy secretary-general of China Health Care Association, after finding the problem of Ginkgo biloba extract, the State Food and Drug Administration will make relevant regulations on the extract to fill the blank of the standard of raw material extract of health food After a large number of Ginkgo biloba extract products are unqualified, it is the rapid growth of China 's health industry market demand In recent years, the incidence rate of cardiovascular and cerebrovascular diseases has been increasing According to the report on nutrition and chronic diseases of Chinese residents (2015) released at the end of June, the prevalence of hypertension in Chinese adults is on the rise In 2012, the prevalence of hypertension in Chinese adults aged 18 and over was 25.2% Cardiovascular and cerebrovascular diseases have become the main cause of death in China, with a mortality rate of 271.8/100000 The report also shows that smoking, excessive drinking, lack of physical activity and unhealthy diet such as high salt and fat are the main behavioral risk factors for the occurrence and development of chronic diseases Yu Zhimin, director of the etiology and pathogenesis research office of the Institute of basic theory of traditional Chinese medicine, Chinese Academy of traditional Chinese medicine, said at the expert seminar on xingantong ginkgo propolis and hawthorn capsule and antioxidant soft capsule held recently that from the perspective of traditional Chinese medicine, lowering blood lipid and antioxidant can be summarized into the category of "removing pathogenic factors", and adjusting immune function belongs to the category of "strengthening" At present, there are many kinds of drugs and health food on the market to regulate blood lipid level Ginkgo biloba leaf has the function of promoting blood circulation, removing blood stasis and unblocking collaterals Yu Zhimin reminded that to prevent and treat chronic diseases, people need to pay attention to a healthy and scientific way of life in their daily life and balance their diet structure It is of great significance to control the level of blood lipid by adjusting diet, exercise and psychology and practicing a healthy lifestyle.